High flow nasal oxygen as a "second-line" therapy for COVID-19 patients intolerant to noninvasive ventilation. A retrospective cohort study
Health Sci Rep
.
2023 Nov 15;6(11):e1685.
doi: 10.1002/hsr2.1685.
eCollection 2023 Nov.
Authors
Federico Lionello
1
,
Gabriella Guarnieri
1
,
Giovanna Arcaro
1
,
Andrea Vianello
1
Affiliation
1
Department of Cardiac, Thoracic and Vascular Sciences University of Padova Padova Italy.
PMID:
38028672
PMCID:
PMC10647974
DOI:
10.1002/hsr2.1685
No abstract available
Keywords:
COVID‐19; acute respiratory failure; high flow nasal oxygen; noninvasive ventilation.